These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 31186275)
21. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death. Kim LH; Peh SC; Poppema S Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421 [TBL] [Abstract][Full Text] [Related]
22. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062 [TBL] [Abstract][Full Text] [Related]
23. Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. Flavell JR; Baumforth KR; Wood VH; Davies GL; Wei W; Reynolds GM; Morgan S; Boyce A; Kelly GL; Young LS; Murray PG Blood; 2008 Jan; 111(1):292-301. PubMed ID: 17720884 [TBL] [Abstract][Full Text] [Related]
24. Classical Hodgkin Lymphoma with Positive Epstein-Barr Virus Status is Associated with More FOXP3 Regulatory T Cells. Pavlovic A; Glavina Durdov M; Capkun V; Jakelic Pitesa J; Bozic Sakic M Med Sci Monit; 2016 Jul; 22():2340-6. PubMed ID: 27377121 [TBL] [Abstract][Full Text] [Related]
25. [Factors involved in host-pathogen interaction for the risk of Hodgkin lymphoma induced by Epstein Barr virus]. Torres Espíndola LM; Arellano Galindo J; Velazquez Cruz R; Castillejos López Mde J Invest Clin; 2013 Sep; 54(3):311-24. PubMed ID: 24354244 [TBL] [Abstract][Full Text] [Related]
26. Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma. Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W Leuk Res; 2021 Aug; 107():106607. PubMed ID: 33957372 [TBL] [Abstract][Full Text] [Related]
27. Frequency of EBV associated classical Hodgkin lymphoma decreases over a 54-year period in a Brazilian population. Campos AHJFM; Moreira A; Ribeiro KB; Paes RP; Zerbini MC; Aldred V; de Souza CA; Neto CS; Soares FA; Vassallo J Sci Rep; 2018 Jan; 8(1):1849. PubMed ID: 29382865 [TBL] [Abstract][Full Text] [Related]
28. Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial. de Lastours V; LeGoff J; Brière J; Agbalika F; Boulet T; Lévy Y; Simon F; Aboulker JP; Molina JM HIV Med; 2014 Jan; 15(1):23-9. PubMed ID: 24007426 [TBL] [Abstract][Full Text] [Related]
29. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients. Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522 [TBL] [Abstract][Full Text] [Related]
30. The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor. Wu R; Sattarzadeh A; Rutgers B; Diepstra A; van den Berg A; Visser L Blood Cancer J; 2016 May; 6(5):e417. PubMed ID: 27152844 [No Abstract] [Full Text] [Related]
31. Hodgkin lymphoma variant of Richter transformation: morphology, Epstein-Barr virus status, clonality, and survival analysis-with comparison to Hodgkin-like lesion. Xiao W; Chen WW; Sorbara L; Davies-Hill T; Pittaluga S; Raffeld M; Jaffe ES Hum Pathol; 2016 Sep; 55():108-116. PubMed ID: 27184478 [TBL] [Abstract][Full Text] [Related]
32. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma. Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575 [TBL] [Abstract][Full Text] [Related]
33. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931 [TBL] [Abstract][Full Text] [Related]
34. A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease. Gan YJ; Razzouk BI; Su T; Sixbey JW Am J Pathol; 2002 Mar; 160(3):781-6. PubMed ID: 11891176 [TBL] [Abstract][Full Text] [Related]
35. [Clinicopathologic features and association with Epstein-Barr virus infection in 235 cases of Hodgkin lymphoma from northern China]. Shi Y; Li X Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):84-9. PubMed ID: 25916637 [TBL] [Abstract][Full Text] [Related]
36. Sequence variation of Epstein-Barr virus (EBV) BCRF1 in lymphomas in non-endemic areas of nasopharyngeal carcinoma. Han L; Sun L; Zhao Z; Chao Y; Sun Z; Li H; Luo B Arch Virol; 2015 Feb; 160(2):441-5. PubMed ID: 25373543 [TBL] [Abstract][Full Text] [Related]
38. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?]. Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676 [TBL] [Abstract][Full Text] [Related]
39. Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults. Palma I; Sánchez AE; Jiménez-Hernández E; Alvarez-Rodríguez F; Nava-Frias M; Valencia-Mayoral P; Salinas-Lara C; Velazquez-Guadarrama N; Portilla-Aguilar J; Pena RY; Ramos-Salazar P; Contreras A; Alfaro A; Espinosa AM; Nájera N; Gutierrez G; Mejia-Arangure JM; Arellano-Galindo J Clin Lymphoma Myeloma Leuk; 2013 Jun; 13(3):266-72. PubMed ID: 23276887 [TBL] [Abstract][Full Text] [Related]
40. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma. Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]